Red Door Wealth Management
PFE icon

Red Door Wealth Management’s Pfizer PFE Stock Holding History

Red Door Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$461K Sell
16,152
-349
-2% -$9.28K 0.04% 196
2026
Q2 		$397K Sell
16,501
-1,846
-10% -$48.3K 0.04% 215
2026
Q1 		$515K Buy
18,347
+9,490
+107% +$253K 0.05% 164
2025
Q4 		$221K Buy
8,857
+338
+4% +$8.52K 0.02% 273
2025
Q3 		$217K Sell
8,519
-253
-3% -$6.24K 0.02% 273
2025
Q2 		$213K Buy
+8,772
New +$205K 0.03% 252
2024
Q4 		– Sell
-163,770
Closed -$4.74M – 237
2024
Q3 		$4.74M Buy
163,770
+8,001
+5% +$233K 0.79% 41
2024
Q2 		$4.36M Buy
155,769
+10,965
+8% +$302K 0.77% 42
2024
Q1 		$4.02M Buy
144,804
+2,674
+2% +$74.2K 0.77% 41
2023
Q4 		$4.09M Buy
142,130
+4,114
+3% +$124K 0.89% 40
2023
Q3 		$4.58M Buy
138,016
+8,743
+7% +$309K 1.14% 29
2023
Q2 		$4.74M Buy
129,273
+5,582
+5% +$217K 1.05% 30
2023
Q1 		$5.05M Buy
123,691
+1,327
+1% +$57.3K 1.58% 21
2022
Q4 		$6.27M Buy
122,364
+6,688
+6% +$321K 2.06% 11
2022
Q3 		$5.06M Buy
115,676
+3,493
+3% +$170K 1.92% 12
2022
Q2 		$5.88M Buy
112,183
+2,563
+2% +$131K 2.18% 9
2022
Q1 		$5.68M Buy
109,620
+8,694
+9% +$451K 1.9% 10
2021
Q4 		$5.96M Buy
100,926
+3,552
+4% +$176K 1.95% 9
2021
Q3 		$4.19M Buy
97,374
+10,876
+13% +$482K 1.6% 16
2021
Q2 		$3.39M Buy
86,498
+10,114
+13% +$393K 1.32% 18
2021
Q1 		$2.77M Buy
76,384
+7,411
+11% +$263K 1.41% 24
2020
Q4 		$2.54M Sell
68,973
-1,083
-2% -$39.7K 1.5% 18
2020
Q3 		$2.44M Buy
70,056
+1,148
+2% +$40.2K 1.8% 15
2020
Q2 		$2.14M Buy
68,908
+2,798
+4% +$95.1K 1.56% 14
2020
Q1 		$2.05M Buy
66,110
+10,041
+18% +$342K 1.94% 13
2019
Q4 		$2.12M Buy
+56,069
New +$2M 1.89% 13

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Red Door Wealth Management's PFE Position: Q3 2026 in Review

Red Door Wealth Management reduced its Pfizer (PFE) stake by 2.1% in Q3 2026, selling an estimated $9.28K and leaving 16,152 shares worth $461K. The position accounts for 0.04% of the portfolio, ranked #196.

Red Door Wealth Management first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.27M in Q4 2022. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Red Door Wealth Management held 16,152 shares of Pfizer worth $461K as of Q3 2026.
  • Red Door Wealth Management sold 349 Pfizer shares in Q3 2026, an estimated $9.28K.
  • Pfizer made up 0.04% of Red Door Wealth Management's portfolio in Q3 2026, its #196 holding.
  • Red Door Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Red Door Wealth Management's Pfizer position peaked at $6.27M in Q4 2022.
  • 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Red Door Wealth Management's 13F filing for Q3 2026, filed 10 Nov 2026.